Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

AIM/VLG stock hub

AIM/VLG has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

AIM/VLGis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

66.4M

London Stock Exchange AIM

Market data

Live price

Current market quote for this ticker.

Current price

AIM/VLG

In the news

Latest news · AIM/VLG

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E13.3

P25 12.9P50 16.9P75 23.5

Trailing P/E10.8

P25 15.9P50 22.9P75 35.8

ROE-2.4

P25 -54.2P50 2.1P75 13.7

ROIC2.1

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All AIM/VLG market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

226

Groups with data

Currency

GBP

Showing 226 of 226 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	UK
Employees	43
Employees Change	-122%
Employees Change Percent	-73.94
Enterprise value	GBX 32.9M
Exchange	London Stock Exchange AIM
Financial currency	GBP
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	GB00BFPM8908
Last refreshed	2026-05-10
Market cap	GBX 66.4M
Price	GBX 54.5
Price currency	GBX
Rev Per Employee	817,837.21x
Sector	Healthcare
Sic	2834
Symbol	aim/VLG
Website	https://www.venture-life.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	9.22%
EV Earnings	5.37x
EV/EBIT	21.49x
EV/EBITDA	5.91x
EV/FCF	92.66x
EV/Sales	0.94x
FCF yield	0.53%
Forward P/E	13.29x
P/B ratio	0.82x
P/E ratio	10.84x
P/S ratio	1.89x
PE Ratio10 Y	89.56x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	4.35%
EBITDA Margin	14.93%
FCF margin	1.01%
Gross margin	45.03%
Gross Profit	GBX 15.8M
Gross Profit Growth	19.14%
Gross Profit Growth Q	18.55%
Gross Profit Growth3 Y	19.44%
Gross Profit Growth5 Y	-2.16%
Net Income	GBX 6.1M
Net Income Growth	725.47%
Net Income Growth Q	452.51%
Net Income Growth Quarters	2%
Net Income Growth Years	1%
Net Income Growth3 Y	88.05%
Net Income Growth5 Y	63.76%
Pretax Margin	-5.51%
Profit Margin	17.42%
Profit Per Employee	GBX 142,442
Profitable Years	1
ROA	0.86
Roa5y	1.43
ROCE	1.73
ROE	-2.44
Roe5y	0.31
ROIC	2.12
Roic5y	1.39

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-0.24%
Cagr1y	21.13%
Cagr3y	9.07%
Cagr5y	-8.61%
Div CAGR3	-20.63%
EPS Growth	782.5
EPS Growth Q	436.4
EPS Growth Quarters	1
EPS Growth Years	1
EPS Growth3 Y	91.7
EPS Growth5 Y	65.15
FCF Growth	-96.64%
FCF Growth3 Y	-64.87%
FCF Growth5 Y	-40.36%
OCF Growth	-96.14%
OCF Growth10 Y	-15.31%
OCF Growth3 Y	-63.49%
OCF Growth5 Y	-40.94%
Revenue Growth	264.01x
Revenue Growth Q	24.84x
Revenue Growth Quarters	1x
Revenue Growth Years	1x
Revenue Growth3 Y	16.28x
Revenue Growth5 Y	-4.37x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	GBX 0.31
Assets	GBX 99.2M
Cash	GBX 34.2M
Current Assets	GBX 50.5M
Current Liabilities	GBX 10.7M
Debt	GBX 667,000
Debt EBITDA	GBX 0.12
Debt Equity	GBX 0.01
Debt FCF	GBX 1.88
Equity	GBX 81.4M
Interest Coverage	1.03
Liabilities	GBX 17.8M
Long Term Assets	GBX 48.7M
Long Term Liabilities	GBX 7M
Net Cash	GBX 33.5M
Net Cash By Market Cap	GBX 50.46
Net Debt EBITDA	GBX -6.38
Net Debt Equity	GBX -0.41
Net Debt FCF	GBX -94.37
Tangible Book Value	GBX 36.5M
Tangible Book Value Per Share	GBX 0.29
WACC	7.26

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.71
Inventory Turnover	4.3
Net Working Capital	GBX 6M
Quick ratio	4.34
Working Capital	GBX 39.8M
Working Capital Turnover	GBX 0.76

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.87%
Dividend per share	GBX 0
Last Dividend	GBX 0

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-2.34%
1Y total return	21.11%
200-day SMA	62.01
3Y total return	29.76%
50-day SMA	65.2
50-day SMA vs 200-day SMA	50over200
5Y total return	-36.26%
All Time High	118
All Time High Change	-53.81%
All Time High Date	2020-11-18
All Time Low	20
All Time Low Change	172.5%
All Time Low Date	2020-03-17
ATR	1.84
Beta	0.24
Beta1y	0.23
Beta2y	0.34
Ch YTD	-17.42
High	56
High52	72
High52 Date	2026-02-12
High52ch	-24.31%
Low	54
Low52	44.5
Low52 Date	2025-05-09
Low52ch	22.47%
Ma50ch	-16.41%
Price vs 200-day SMA	-12.11%
RSI	14.15
RSI Monthly	51.7
RSI Weekly	33.14
Sharpe ratio	0.62x
Sortino ratio	1.23
Total Return	-4.87%
Tr YTD	-17.42
Tr1m	-14.84%
Tr1w	-3.54%
Tr3m	-21.58%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	GBX 1.5M
Operating Income Growth	-48.5
Operating Income Growth Q	-39.65
Operating Income Growth3 Y	-9.12
Operating Income Growth5 Y	-15.27
Operating margin	4.35

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	105,392,520%
Net Borrowing	-22,513,000
Shares Insiders	3.14%
Shares Institutions	87.86%
Shares Out	121,828,073
Shares Qo Q	19.2%
Shares Yo Y	4.87%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	GBX -26,000
Average Volume	230,889.3x
Bv Per Share	0.64
CAPEX	GBX -45,000
Ch10y	-2.68
Ch1m	-14.84
Ch1w	-3.54
Ch1y	21.11
Ch3m	-21.58
Ch3y	29.76
Ch5y	-36.26
Ch6m	1.87
Change	-1.8%
Change From Open	-0.91
Close	55.5
Days Gap	-0.9
Depreciation Amortization	3,719,000
Dollar Volume	86,833,542
Earnings Date	2026-05-13
EBIT	GBX 1.5M
EBITDA	GBX 5.3M
EPS	GBX 0.05
F Score	6
FCF	GBX 355,000
FCF EV Yield	1.08x
FCF Per Share	GBX 0
Financing CF	-24,429,000
Fiscal Year End	December
Founded	2,005
Goodwill	15,387,000
Graham Number	83.119
Graham Upside	52.51
Income Tax	GBX -25,000
Investing CF	53,983,000
Is Primary Listing	1
Last Earnings Date	2025-09-22
Last Report Date	2025-12-31
Lynch Fair Value	GBX 120
Lynch Upside	119.7
Ma150	63.13
Ma150ch	-13.68%
Ma20	61.54
Ma20ch	-11.43%
Net CF	29,849,000
Next Earnings Date	2026-05-13
Open	55
P FCF Ratio	187
P OCF Ratio	166
Position In Range	25
Ppne	446,000
Price Date	2026-05-08
Price EBITDA	GBX 12.65
Ptbv Ratio	1.82
Relative Volume	8.09x
Revenue	35,167,000x
SBC By Revenue	1.08x
Share Based Comp	381,000
Tax By Revenue	-0.07x
Tr6m	1.87%
Volume	1,593,276
Z Score	3.28

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does AIM/VLG pay a dividend?

Capital-return profile for this ticker.

Performance

AIM/VLG stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns AIM/VLG?

Insider, institutional, and short-interest positioning.

Institutional ownership

+87.9%

Share of float held by funds and institutions

Insider ownership

+3.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+4.9%

Negative means the company is buying back shares.

Technical

AIM/VLG momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

14.1

Below 30: short-term oversold

Price vs 200-day MA

-12.1%

50/200-day relationship not available

Beta (5Y)

0.24

Less volatile than the market

Sharpe ratio

0.62

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About AIM/VLG

Hub-level FAQ points readers to the deeper analysis pages.

What is the current aim/VLG stock rating?

aim/VLG is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full aim/VLG analysis?

The full report lives at /stocks/aim/VLG/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for aim/VLG?

The latest report frames aim/VLG around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the aim/VLG page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.